Personalized cancer vaccines (PCVs) are reinvigorating vaccine strategies in cancer
immunotherapy. In contrast to adoptive T-cell therapy and checkpoint blockade, the PCV …

Cancer immunotherapy is an effective antitumor approach through activating immune
systems to eradicate tumors by immunotherapeutics. However, direct administration of …

Cell therapy has revolutionized the treatment of various diseases, such as cancers, genetic
disorders, and autoimmune diseases. Currently, most cell therapy products rely on ex vivo …

The development of nanovaccines that employ polymeric delivery carriers has garnered
substantial interest in therapeutic treatment of cancer and a variety of infectious diseases …

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) rapidly infects
humans and animals which make coronavirus disease 2019 (COVID-19) a grievous …

Therapeutic targeting of the immune system, including chimeric antigen receptor-T cell
therapy, immune checkpoint blockade therapy, neoantigen vaccines, and small molecule …

Abstract mRNA gene therapy has recently emerged as a candidate to enable multiple
therapeutic applications including protein replacement therapy, vaccine immunology, and …

Vaccination programmes provide a safe, effective and cost‐efficient strategy for maintaining
population health. In veterinary medicine, vaccination not only reduces disease within …

Developing adjuvant vaccines to combat rising multidrug-resistant (MDR) Acinetobacter
baumannii (A. baumannii) infections is a promising and cost-effective approach. The aim of …

Polymer-based nanoparticles of tailored size, morphology, and surface properties have
attracted increasing attention as carriers for drugs, biomolecules, and genes. By protecting …